Oxford Biomedica PLC Director/PDMR Shareholding (8361U)
January 23 2017 - 4:57AM
UK Regulatory
TIDMOXB
RNS Number : 8361U
Oxford Biomedica PLC
23 January 2017
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC
------ ------------------------ ----------------------------------
2 Reason for notification Notification relates to DTR
3.1.2R
------ ------------------------ ----------------------------------
3 Name of PDMR Martin Diggle
------ ------------------------ ----------------------------------
4 Connected person Notification relates to following
connected persons:
Vulpes Life Sciences Fund
------ ------------------------ ----------------------------------
5 Notification Notification in respect of
in respect of holdings of persons in 4 above
------ ------------------------ ----------------------------------
6 Description Oxford BioMedica PLC ordinary
of shares shares of 1p each
------ ------------------------ ----------------------------------
7 Name of registered Vulpes Life Sciences Fund
shareholders - 547,432,000 shares
and number of Vulpes Testudo Fund - 33,333,333
shares shares
------ ------------------------ ----------------------------------
8 Nature of transaction Acquisition
------ ------------------------ ----------------------------------
9 Number of shares Vulpes Life Sciences Fund
acquired - 1,700,000 shares
------ ------------------------ ----------------------------------
10 Percentage of Vulpes Life Sciences Fund
issued class - 0.05%
acquired
------ ------------------------ ----------------------------------
11 Shares disposed N/A
------ ------------------------ ----------------------------------
12 Percentage of N/A
issued class
disposed
------ ------------------------ ----------------------------------
13/14 Price per share Vulpes Life Sciences Fund
of transactions, 1,100,000 shares @ GBP0.0420
and date , 19 Jan 2017
600,000 shares @ GBP0.0420
, 20 Jan 2017
------ ------------------------ ----------------------------------
15 Total holding Vulpes Life Sciences Fund
following notification - 549,132,000 shares
and total percentage 17.78%
holding following Vulpes Testudo Fund - 33,333,333
notification shares
1.08%
------ ------------------------ ----------------------------------
16 Date issuer 23 Jan 2017
informed
------ ------------------------ ----------------------------------
23 Any additional None
information
------ ------------------------ ----------------------------------
24 Contact name T. Watts, Chief Financial
and telephone Officer
number Oxford BioMedica
+44 (0)1865 783000
------ ------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDBLUDBGRX
(END) Dow Jones Newswires
January 23, 2017 04:57 ET (09:57 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Sep 2023 to Sep 2024